RFR-Page 2
A. Please list all applicable statutory references (MCLs, Executive Orders, etc.).
By authority conferred on the department of health and human services by sections 2221,
2226, and 2233 of the public health code, 1978 PA 368, MCL 333.2221, 333.2226, and
333.2233, and Executive Reorganization Order No. 2015-1, MCL 400.227.
B. Are the rules mandated by any applicable constitutional or statutory provision? If so,
please explain.
The proposed rules are not mandated by any applicable constitutional or statutory provision.
9. Please describe the extent to which the rules conflict with or duplicate similar rules,
compliance requirements, or other standards adopted at the state, regional, or federal level.
The rules do not conflict with or duplicate other rules, compliance requirements, or other standards
adopted at the state, regional, or federal level.
10. Is the subject matter of the rules currently contained in any guideline, handbook, manual,
instructional bulletin, form with instructions, or operational memoranda?
The subject matter of the proposed rules is contained in guidelines, manuals, forms, and operational
memoranda.
11. Are the rules listed on the department’s annual regulatory plan as rules to be processed for
the current year?
The rules are listed on the current year annual regulatory plan.
12. Will the proposed rules be promulgated under Section 44 of the administrative procedures act
of 1969, 1969 PA 306, MCL 24.244, or under the full rulemaking process?
Full Process
13. Please describe the extent to which the rules exceed similar regulations, compliance
requirements, or other standards adopted at the state, regional, or federal level.
The rules do not conflict with or duplicate other rules, compliance requirements, or other standards
adopted at the state, regional, or federal level.
14. Do the rules incorporate the recommendations received from the public regarding any
complaints or comments regarding the rules? If yes, please explain.
Clinicians from the University of Michigan ALS clinic contacted the department and requested the
development of an ALS case registry and to make ALS a reportable condition. There are currently
two ALS registries in the United States: 1. National registry that is a passive data system and is
insufficient for Michigan surveillance and 2. Massachusetts Arego Paul Cellucci Registry, which is an
active surveillance system based on mandatory reporting of ALS. The U of M team felt that the
abstraction process detailed in Massachusetts is sufficient and collects appropriate secondary data
use elements. The elements collected in Massachusetts allow determination of the number of ALS
cases in the state, identify any gaps in care, identify underserved areas, assess for hotspots, and
understand if the number of cases are increasing over time (which is what U of M is seeing in their
clinics). The U of M team has stressed the importance of making ALS reportable to their patients and
their families. In addition, the ALS registry and reporting has the full support of all 4 ALS clinics and
their staff in Michigan.
15. If amending an existing rule set, please provide the date of the last evaluation of the rules and
the degree, if any, to which technology, economic conditions, or other factors have changed
the regulatory activity covered by the rules since the last evaluation.
This is a new rule set.
16. Are there any changes or developments since implementation that demonstrate there is no
continued need for the rules, or any portion of the rules?
This is a new rule set.
17. Is there an applicable decision record (as defined in MCL 24.203(6) and required by MCL
24.239(2))? If so, please attach the decision record.
No
MCL 24.239